We have detected new molecular aspects of obesity-derived effects on placentas, where the glucocorticoid receptor signalling pathway and dysregulation of several genes including CCL2, FSTL3, IGFBP1, MMP12, PRG2, PRL, QSOX1, SERPINE2 and TAC3 might have important roles. The gene discussed is TAC3; the disease is obesity due to melanocortin 4 receptor deficiency.